HomeCOEP • NASDAQ
add
Coeptis Therapeutics Holdings Inc
Previous close
$12.47
Day range
$6.26 - $11.17
Year range
$2.31 - $13.70
Market cap
26.30M USD
Avg Volume
40.21K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.16M | -35.76% |
Net income | -1.95M | 48.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.91M | 38.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 532.88K | -63.73% |
Total assets | 8.91M | 94.89% |
Total liabilities | 5.04M | 34.18% |
Total equity | 3.87M | — |
Shares outstanding | 3.36M | — |
Price to book | 8.26 | — |
Return on assets | -60.52% | — |
Return on capital | -89.91% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.95M | 48.13% |
Cash from operations | -1.44M | 15.19% |
Cash from investing | 100.00K | — |
Cash from financing | 731.97K | -58.21% |
Net change in cash | -604.57K | -1,149.16% |
Free cash flow | 520.45K | 287.56% |
About
Founded
2017
Headquarters
Website
Employees
5
